Danske Bank’s Tectonic Therapeutic TECX Stock Holding History

Danske Bank’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2	Closed	-$61	–	1678
2024 Q3	$61	Buy	+2	New	+$37	﹤0.01%	1468

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Danske Bank's TECX Position: Q4 2024 in Review

Danske Bank sold out of Tectonic Therapeutic (TECX) in Q4 2024, closing a stake of 2 shares — an estimated $61 sold.

Danske Bank first reported a position in TECX in Q3 2024 and held it in 1 quarter. The position peaked at $61 in Q3 2024. 70 funds tracked by Wall St. Rank hold TECX as of Q4 2024.

Danske Bank reported no remaining Tectonic Therapeutic position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 2 Tectonic Therapeutic shares in Q4 2024, an estimated $61.
Danske Bank first reported a position in Tectonic Therapeutic in Q3 2024 and held it in 1 quarter.
Danske Bank's Tectonic Therapeutic position peaked at $61 in Q3 2024.
70 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.